439 related articles for article (PubMed ID: 22931254)
1. Comparison of plain vertebral X-ray and dual-energy X-ray absorptiometry for the identification of older women for fracture prevention in primary care.
Robinson PJ; Bell RJ; Lanzafame A; Segal L; Kirby C; Piterman L; Davis SR
Intern Med J; 2013 Jan; 43(1):38-45. PubMed ID: 22931254
[TBL] [Abstract][Full Text] [Related]
2. Simplifying screening for osteoporosis in Australian primary care: the Prospective Screening for Osteoporosis; Australian Primary Care Evaluation of Clinical Tests (PROSPECT) study.
Davis SR; Kirby C; Weekes A; Lanzafame A; Piterman L
Menopause; 2011 Jan; 18(1):53-9. PubMed ID: 20711081
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of vertebral fracture assessment to detect prevalent vertebral deformity and select postmenopausal women with a femoral neck T-score>-2.5 for alendronate therapy: a modeling study.
Schousboe JT; Ensrud KE; Nyman JA; Kane RL; Melton LJ
J Clin Densitom; 2006; 9(2):133-43. PubMed ID: 16785071
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of vitamin D deficiency and relationship with fracture risk in older women presenting in Australian general practice.
Robinson PJ; Bell RJ; Lanzafame A; Kirby C; Weekes A; Piterman L; Davis SR
Australas J Ageing; 2013 Sep; 32(3):177-83. PubMed ID: 24028458
[TBL] [Abstract][Full Text] [Related]
5. Vertebral fracture assessment by dual-energy X-ray absorptiometry along with bone mineral density in the evaluation of postmenopausal osteoporosis.
Shetty S; John B; Mohan S; Paul TV
Arch Osteoporos; 2020 Feb; 15(1):25. PubMed ID: 32095943
[TBL] [Abstract][Full Text] [Related]
6. Quantitative computed tomography of the lumbar spine, not dual x-ray absorptiometry, is an independent predictor of prevalent vertebral fractures in postmenopausal women with osteopenia receiving long-term glucocorticoid and hormone-replacement therapy.
Rehman Q; Lang T; Modin G; Lane NE
Arthritis Rheum; 2002 May; 46(5):1292-7. PubMed ID: 12115236
[TBL] [Abstract][Full Text] [Related]
7. Universal bone densitometry screening combined with alendronate therapy for those diagnosed with osteoporosis is highly cost-effective for elderly women.
Schousboe JT; Ensrud KE; Nyman JA; Melton LJ; Kane RL
J Am Geriatr Soc; 2005 Oct; 53(10):1697-704. PubMed ID: 16181168
[TBL] [Abstract][Full Text] [Related]
8. Calcaneus ultrasonometry and dual-energy X-ray absorptiometry for the evaluation of vertebral fracture risk.
Frediani B; Acciai C; Falsetti P; Baldi F; Filippou G; Siagkri C; Spreafico A; Galeazzi M; Marcolongo R
Calcif Tissue Int; 2006 Oct; 79(4):223-9. PubMed ID: 16969597
[TBL] [Abstract][Full Text] [Related]
9. Quantitative bone ultrasound at phalanges and calcaneus in osteoporotic postmenopausal women: influence of age and measurement site.
Camozzi V; De Terlizzi F; Zangari M; Luisetto G
Ultrasound Med Biol; 2007 Jul; 33(7):1039-45. PubMed ID: 17445968
[TBL] [Abstract][Full Text] [Related]
10. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis.
Meunier PJ; Roux C; Seeman E; Ortolani S; Badurski JE; Spector TD; Cannata J; Balogh A; Lemmel EM; Pors-Nielsen S; Rizzoli R; Genant HK; Reginster JY
N Engl J Med; 2004 Jan; 350(5):459-68. PubMed ID: 14749454
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of alendronate in the treatment of postmenopausal women in 9 European countries--an economic evaluation based on the fracture intervention trial.
Ström O; Borgström F; Sen SS; Boonen S; Haentjens P; Johnell O; Kanis JA
Osteoporos Int; 2007 Aug; 18(8):1047-61. PubMed ID: 17333449
[TBL] [Abstract][Full Text] [Related]
12. Prospective evaluation of risk of vertebral fractures using quantitative ultrasound measurements and bone mineral density in a population-based sample of postmenopausal women: results of the Basel Osteoporosis Study.
Hollaender R; Hartl F; Krieg MA; Tyndall A; Geuckel C; Buitrago-Tellez C; Manghani M; Kraenzlin M; Theiler R; Hans D
Ann Rheum Dis; 2009 Mar; 68(3):391-6. PubMed ID: 18417517
[TBL] [Abstract][Full Text] [Related]
13. Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention Trial.
Ensrud KE; Black DM; Palermo L; Bauer DC; Barrett-Connor E; Quandt SA; Thompson DE; Karpf DB
Arch Intern Med; 1997 Dec 8-22; 157(22):2617-24. PubMed ID: 9531231
[TBL] [Abstract][Full Text] [Related]
14. [Vertebral fractures, osteoporosis and vitamin D levels in Chilean postmenopausal women].
Rodríguez P JA; Valdivia C G; Trincado M P
Rev Med Chil; 2007 Jan; 135(1):31-6. PubMed ID: 17369981
[TBL] [Abstract][Full Text] [Related]
15. Clinical review: Clinical applications of vertebral fracture assessment by dual-energy x-ray absorptiometry.
Lewiecki EM; Laster AJ
J Clin Endocrinol Metab; 2006 Nov; 91(11):4215-22. PubMed ID: 16940447
[TBL] [Abstract][Full Text] [Related]
16. The relationship between phalangeal bone density and vertebral deformities.
Versluis RG; Petri H; Vismans FJ; van de Ven CM; Springer MP; Papapoulos SE
Calcif Tissue Int; 2000 Jan; 66(1):1-4. PubMed ID: 10602836
[TBL] [Abstract][Full Text] [Related]
17. Vertebral bone attenuation on low-dose chest CT: quantitative volumetric analysis for bone fragility assessment.
Kim YW; Kim JH; Yoon SH; Lee JH; Lee CH; Shin CS; Park YS
Osteoporos Int; 2017 Jan; 28(1):329-338. PubMed ID: 27480628
[TBL] [Abstract][Full Text] [Related]
18. Morphometric X-ray absorptiometry and morphometric radiography of the spine: a comparison of prevalent vertebral deformity identification.
Rea JA; Chen MB; Li J; Blake GM; Steiger P; Genant HK; Fogelman I
J Bone Miner Res; 2000 Mar; 15(3):564-74. PubMed ID: 10750572
[TBL] [Abstract][Full Text] [Related]
19. Digital vertebral morphometry performed by DXA: a valuable opportunity for identifying fractures during bone mass assessment.
Muszkat P; Camargo MB; Peters BS; Kunii LS; Lazaretti-Castro M
Arch Endocrinol Metab; 2015 Apr; 59(2):98-104. PubMed ID: 25993670
[TBL] [Abstract][Full Text] [Related]
20. Potential cost-effective use of spine radiographs to detect vertebral deformity and select osteopenic post-menopausal women for amino-bisphosphonate therapy.
Schousboe JT; Ensrud KE; Nyman JA; Kane RL; Melton LJ
Osteoporos Int; 2005 Dec; 16(12):1883-93. PubMed ID: 16133649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
